SOLO 1: Olaparib in BRCA mutated patients Last updated on Jul 24, 2024 Previous SCOTROC: Carboplatin Docetaxel in Ovarian Cancer Next Primary Treatment of High-Grade Ovarian/Fallopian Tube Carcinoma
